#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Gastroenterology and Hepatology - Issue 1/2023

Editorial

3
Editorial

M. Lukáš

5
Editorial

M. Bortlík


Quiz

11
Fatal course of an infl ammatory disease

M. Bortlík


14
Two years of the COVID-19 pandemic in the population of Czech patients with infl ammatory bowel disease treated with bio logical therapy – experience of the tertiary IBD center

K. Černá, M. Lukáš


IBD: Case Report

21
Primary signet ring cell adenocarcinoma as a rare cause of colonic stenosis in a young patient with Crohn’s disease – the case report

B. Pipek-, K. Prokešová, R. Kotásek, Martin Štěpán, P. Fojtík


26
Biological therapy of ulcerative colitis during pregnancy

J. Koželuhová

30
Complicated course of IBD in pregnancy

V. Štěpánek, Z. Šerclová, M. Kasalický, M. Bortlík-


34
On the question of the interchangeability of monoclonal bio similar antibodies in the treatment of immune-mediated infl ammatory diseases

M. Lukáš, L. Šenolt, S. Gkalpakiotis


Clinical and Experimental Gastroenterology: Original Article

38
Gastrointestinal dysfunctions and their influence on the quality of life in aging adults with spinal cord injury

J. Štěpánová, P. Pliska, K. Raisová

43
Epidemiological and demographic characteristics of individuals with irritable bowel syndrome based on the Rome III vs. Rome IV criteria in the Northern part of Serbia

D. Slankamenac, D. Dabic, A. Dabic, T. Slankamenac, A. Preveden


Hepatology: case report

52
Autoimmune hepatitis after vaccination against COVID-19

V. Pítová, J. Šperl, P. Taimr, O. Fabián, T. Miřejovský, L. Janoušek, J. Chlupáč, J. Špičák, S. Fraňková


57
The selection from international journals

MUDr. Mgr. Irena Míková, MUDr. Kristýna Kaštylová, MUDr. Vincent Zoundjiekpon, MUDr. Silvia Cveková


61
17th educational and discussion gastroenterology days

O. Urban

64
Therapeutic monitoring of bio­logics: on the way to personalized medicine

K. Černá


66
Professor Ryska has passed away, his legacy remains
67
Assoc. Prof. Igor Kajaba, MD, PhD.

69
Kreditovaný autodidaktický test

70
Overview of the most common skin adverse reactions of bio­logical treatment in patients with inflammatory bowel disease – part 1

M. Nováková


78
Tofacitinib – is it time for a change in treatment in ulcerative colitis?

Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#